Correction for chromosome-17 is critical for the determination of trueHer-2/neugene amplification status in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Correction for chromosome-17 is critical for the determination of trueHer-2/neugene amplification status in breast cancer

Published:2006-10 Issue:10 Volume:5 Page:2572-2579
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Dal Lago Lissandra,Durbecq Virginie,Desmedt Christine,Salgado Roberto,Verjat Thibault,Lespagnard Laurence,Ma Yan,Veys Isabelle,Di Leo Angelo,Sotiriou Christos,Piccart Martine,Larsimont Denis

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amplification of Chromosome 17 Centromere (CEP17) in Breast Cancer Patients with a Result of HER2 2± by Immunohistochemistry;Cancer Investigation;2020-01-29

2. The effect of an alternative chromosome 17 probe on fluorescence in�situ hybridization for the assessment of HER2 amplification in invasive breast cancer;Experimental and Therapeutic Medicine;2019-07-09

3. MDM2 copy number increase: a poor prognostic, molecular event in esophageal squamous cell carcinoma;Human Pathology;2019-07

4. Correlation Between HER-2 Gene Amplification or Protein Expression and Clinical Pathological Features of Breast Cancer;Cancer Biotherapy and Radiopharmaceuticals;2019-02

5. Identification of HER2 Immunohistochemistry-Negative, FISH-Amplified Breast Cancers and Their Response to Anti-HER2 Neoadjuvant Chemotherapy;American Journal of Clinical Pathology;2018-10-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP